A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

A Pooled Analysis of Infections, Malignancy, and Mortality in Infliximab- and Immunomodulator-Treated Adult Patients With Inflammatory Bowel Disease

Published:2012-07 Issue:7 Volume:107 Page:1051-1063
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:

Author:

Lichtenstein Gary R,Rutgeerts Paul,Sandborn William J,Sands Bruce E,Diamond Robert H,Blank Marion,Montello Jennifer,Tang Linda,Cornillie Freddy,Colombel Jean-Frédéric

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg201289.pdf

Reference20 articles.

1. How to improve the safety of biologic therapy in Crohns disease.;Ferkolj;J Physiol Pharmacol,2009

2. Methotrexate for maintenance of remission in Crohns disease.;Patel;Cochrane Database Sys Rev,2009

3. Thiopurine therapy in inflammatory bowel disease.;Ha;Expert Rev Gastroenterol Hepatol,2010

4. Maintenance infliximab for Crohns disease: the ACCENT I randomised trial.;Hanauer;Lancet,2002

5. Comparison of scheduled and episodic treatment strategies of infliximab in Crohns disease.;Rutgeerts;Gastroenterology,2004

Cited by 196 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease;The Korean Journal of Gastroenterology;2024-06-25

2. Oral Administration of PLGA Nanoparticles to Deliver Antisense Oligonucleotides to Inflammatory Lesions in the Gastrointestinal Tract;Biological and Pharmaceutical Bulletin;2024-04-15

3. Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future;Future Pharmacology;2024-03-14

4. Clinical use of biologics for Crohn’s disease in adults: lessons learned from real-world studies;Expert Opinion on Biological Therapy;2024-02-23

5. Identifying risk factors of anti‐TNF induced skin lesions and other adverse events in paediatric patients with inflammatory bowel disease;Journal of Pediatric Gastroenterology and Nutrition;2023-12-10